Merck says its new Covid pill reduces the risk of hospitalization, death by half for some patients

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 72%

ICYMI: Merck plans to seek emergency use authorization 'as soon as possible' for its Covid-19 oral antiviral treatment. megtirrell reports.

Ridgeback Biotherapeutics CEO Wendy Holman added: "With the virus continuing to circulate widely, and because therapeutic options currently available are infused or require access to a healthcare facility, antiviral treatments that can be taken at home to keep people with Covid-19 out of the hospital are critically needed."

If authorized by regulatory bodies, molnupiravir could be the first oral antiviral medicine for Covid. Antiviral treatments now in use, such as remdesivir, are administered intravenously. The company agreed earlier this year to supply the U.S. with around 1.7 million courses of molnupiravir if it receives emergency use authorization or full approval from the FDA. The federal government also has the option to purchase additional doses if the drug is approved, White House coronavirus response coordinator Jeff Zients said at Friday's briefing.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Merck Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key StudyMerck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment
Baca lebih lajut »

Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key StudyMerck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment
Baca lebih lajut »

Brett Kavanaugh tested negative for COVID ahead of meeting other SCOTUS members on MondayBrett Kavanaugh tested negative for COVID ahead of meeting other SCOTUS members on MondayKavanaugh is the first sitting justice to test positive for the virus, although he is not showing symptoms.
Baca lebih lajut »

School Boards Ask for Federal Help as Tensions Rise Over Covid-19 PoliciesAn organization representing school boards across the U.S. is asking the federal government for help in response to threats and harassment over Covid-19 protocols in schools
Baca lebih lajut »

California To Require All Schoolchildren To Get COVID-19 ShotsCalifornia To Require All Schoolchildren To Get COVID-19 ShotsCalifornia has announced the nation's first coronavirus vaccine mandate for schoolchildren.
Baca lebih lajut »

Covid-19 Deaths in U.S. Level Off as Delta Variant Surge EasesThe seven-day average for daily new Covid-19 deaths in the U.S. has hovered near 2,000 for more than a week, after a two-month climb during which more than 80,000 additional deaths were reported.
Baca lebih lajut »



Render Time: 2025-04-16 21:26:59